Search results
FDA Tells Vaccine Makers to Target New COVID Variant for Fall
WFMZ Eastern Pennsylvania and Western New Jersey· 10 hours agoCOVID vaccine makers will be advised to update their shots to target the KP.2 variant, an offshoot...
Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know
Zacks· 5 days agoFree Report) is one of the stocks most watched by Zacks.com visitors lately. The Zacks Medical - Biomedical and Genetics industry, to which Novavax belongs, has gained 0.9% ...
FDA asks COVID vaccine makers to target KP.2 strain with updated shots
Reuters· 2 hours agoThe U.S. Food and Drug Administration recommended COVID-19 vaccine makers target the KP.2 strain...
KP.3 is the dominant COVID-19 variant in the US: Latest on test positivity, deaths, symptoms
USA Today· 1 day agoCases of the latest COVID-19 variant, also known as KP.3, are on the rise in the United States....
Novavax (NASDAQ:NVAX) Shares Gap Down to $19.56
ETF DAILY NEWS· 6 days agoShares of Novavax, Inc. (NASDAQ:NVAX – Get Free Report) gapped down before the market opened on Friday . The stock had previously closed at $19.56, but opened at $18.79. & ...
FDA advises Covid vaccine makers to target KP.2 for fall shots
NBC NEWS· 24 hours agoThe Food and Drug Administration said Thursday it had advised drugmakers to update the Covid...
Bull Market and Beyond: 3 Stocks Just Waiting to Soar
The Motley Fool via AOL· 3 days agoYou'll find plenty of these stocks in the area of biotech and pharma -- let's check out three in...
Novavax And Agios Pharmaceuticals Were Among The 10 Biggest Mid-Cap Gainers Last Week (June 1-June...
Benzinga· 5 days agoMid-cap stocks saw significant gains last week, with top performers like AGIO, VRNT, and NVAX,...
COVID Variant KP.3 Surges to Dominance—Here's What You Need to Know
Health via Yahoo News· 1 day agoDo Vaccines Protect Against KP.3? Per Zambrano, all three COVID vaccine manufacturers—Pfizer,...
FDA modifies strain recommendation for fall COVID vaccine amid variant shifts, uptick in cases
Center for Infectious Disease Research and Policy· 3 hours agoOn June 5, the FDA's vaccine advisory group recommended a switch to the JN.1 variant, though it held...